“Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment.”, J Clin Invest, vol. 124, no. 7, pp. 3121-8, 2014.
, “Umbilical Cord Blood Expansion with Nicotinamide Provides Long-Term Multilineage Engraftment”, J Clin Invest, vol. 124, pp. 3121-3128, 2014.
, , “Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT).”, Biol Blood Marrow Transplant, vol. 11, no. 2, pp. 149-60, 2005.
, “Umbilical Cord Blood Transplantation in Adults: Results of the Prospective Cord Blood Transplantation (COBLT)”, Biol Blood Marrow Transplant, vol. 11, pp. 2149-2160, 2005.
, “Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes.”, Biol Blood Marrow Transplant, vol. 23, no. 10, pp. 1714-1721, 2017.
, “Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-Exposure Prophylaxis Among Men Who Have Sex With Men in Kenya”, AIDS Behav, vol. 19, pp. 794-801, 2015.
, “Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya.”, AIDS Behav, vol. 19, no. 5, pp. 794-801, 2015.
, “Understanding hospital readiness for computerized physician order entry.”, Jt Comm J Qual Saf, vol. 29, no. 7, pp. 336-44, 2003.
, “Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).”, Biol Blood Marrow Transplant, vol. 18, no. 8, pp. 1265-72, 2012.
, “Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)”, Biol Blood Marrow Transplant, vol. 18, pp. 1265-1272, 2012.
, “Untitled”, 2000.
, “Untitled”, 2004.
, “Untitled”, 2001.
“Update from studies in pediatric liver transplantation.”, Transplant Proc, vol. 33, no. 7-8, pp. 3604-5, 2001.
, “Updated multivariate analyses of patient characteristics as predictors of survival in hormone-refractory prostate cancer patients treated with suramin”, Cancer Epidemiology, Biomarkers & Prevention, vol. 7, pp. 631-34, 1998.
, “Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0.”, J Clin Oncol, p. JCO2003613, 2021.
, “Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system.”, Prev Med, vol. 110, pp. 31-37, 2018.
, “Use of Biological Assignment in Hematopoietic Stem Cell Transplantation Clinical Trials”, Clin Trials, vol. 5, pp. 607-616, 2008.
, “Use of biological assignment in hematopoietic stem cell transplantation clinical trials.”, Clin Trials, vol. 5, no. 6, pp. 607-16, 2008.
, “Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-bli”, Lancet Infect Dis, vol. 16, no. 1, pp. 31-42, 2016.
, “Use of low-dose tacrolimus and associated hypomagnesemia in the prevention of erectile dysfunction following prostatectomy for prostate cancer.”, Pharmacol Rep, vol. 68, no. 6, pp. 1154-1158, 2016.
, , “Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to Adolescents”, Clin Pharmacol Ther, vol. 96, pp. 429-437, 2014.
, “Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.”, Clin Pharmacol Ther, vol. 96, no. 4, pp. 429-37, 2014.
,